Expert faculty share evidence-based and patient-centered guidance in sessions presented during September 10 NEI Saturday Morning Live
Trouble viewing this email? Read it online
Learn the Latest and Greatest in the Diagnosis and Treatment of Depression

2022 SML

Major Depressive Disorder (MDD) is a highly prevalent and disabling condition for which the currently available treatments are not fully effective. Ongoing research continuously leads to new therapeutic options for identifying and treating resistant depression with which most clinicians are not yet familiar.

Register for free today to attend NEI Saturday Morning Live on September 10 and hear about diagnosis strategies and antidepressant agents that are being explored in the session titled, “The Latest and Greatest in Diagnosis and Treatment of Major Depressive Disorder.”

This session presented by Joseph Goldberg, MD is part of the 2.5 CME/CE credits attendees can earn and will help you:

  • RECOGNIZE the presentation of MDD 
  • MONITOR patients with MDD for adequate response and adherence to antidepressant therapy
  • ADJUST treatment plans for patients with inadequate treatment response or nonadherence, utilizing switching and adjunctive medication strategies
  • ASSESS clinical data on novel and emerging medications for MDD and treatment-resistant depression

Join us on September 10 for this complimentary program and learn the latest and greatest in the diagnosis and treatment of depression.

Register Now


 
Neuroscience Education Institute
5900 La Place Court, Suite 120
Carlsbad California 92008
United States

You are subscribed to this mailing list as [email protected]. Please click here to modify your message preferences or to unsubscribe from any future mailings. We will respect all unsubscribe requests.